A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder

Proposed use: Ulcerative colitis Proposed forms: Oral capsules, nasal spray, injections, transdermal cream, rectal suppository Proposed use: Wound healing Proposed forms: Subcutaneous or intramuscular injection Secret To Weight Loss May Be Hiding In Your Gut, New Study Suggests Proposed use: Wound healing and inflammatory condition Proposed forms: Cream and gel Proposed use: Obesity and osteoporosis Proposed forms: Subcutaneous injection Proposed use: Cerebral ischemia (shortage of blood flow and oxygen to the brain), migraine and trigeminal neuralgia (chronic pain condition in the face) Proposed form: Intranasal spray, subcutaneous injection Click Here To Sign Up For Our Health Newsletter Proposed use: Opioid withdrawal, chronic insomnia, narcolepsy Proposed form: Subcutaneous injection Proposed use: Insomnia Proposed form: Subcutaneous injection Performance medicine and peptide expert Dr

Brayden- UCD Conway Institute, Veterinary Sciences Centre, University College Dublin, Belfield, Dublin, Ireland Rationale Oral administration of peptides for systemic delivery offers convenience for patients and promotes better adherence to dosing regimens than injections
Mesoporous bioactive glass (MBG) is currently in the spotlight of regenerative medicine